Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cochlear ( (AU:COH) ) has provided an update.
Cochlear Limited has notified the market of the cessation of several classes of equity-linked securities, including options, performance rights, deferred performance rights and service rights. The affected instruments, which collectively cover several thousand potential shares, are tied to employee or executive incentive schemes.
The securities have lapsed or expired as of 31 March 2026, primarily because options were not exercised and certain performance or service conditions were not met or became incapable of being satisfied. The move marginally reduces the company’s pool of outstanding equity incentives, slightly limiting potential future dilution for existing shareholders while signalling that some performance hurdles under prior plans were not achieved.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$172.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a medical device company specialising in implantable hearing solutions, including cochlear implants and related hearing technologies. Listed on the ASX under the code COH, it targets patients with moderate to profound hearing loss and operates globally in the hearing health and audiology markets.
YTD Price Performance: -33.04%
Average Trading Volume: 221,424
Technical Sentiment Signal: Sell
Current Market Cap: A$11.27B
For an in-depth examination of COH stock, go to TipRanks’ Overview page.